Gulf Medical University College of Medicine and ScholarRx Announce Medical Education Partnership

LOUISVILLE, Ky., Dec. 2, 2020 /PRNewswire/ — Today the Gulf Medical University College of Medicine (GMU) and ScholarRx announced a collaboration to further the College’s educational mission. GMU has adopted the Rx Bricks online service from ScholarRx, a revolutionary digital learning platform that supports the curriculum and enhances pre-clinical instruction.

Prof. Hossam Hamdy, Chancellor, Gulf Medical University states, “Gulf Medical University’s partnership with ScholarRx ensures that the content of the medical curriculum is benchmarked with similar top U.S. medical colleges using the same program. The Rx Bricks of ScholarRx provide our students with up-to-date medical knowledge through educationally sound courses delivered by expert faculty. As a leading medical university in the Middle East, Gulf Medical University will contribute to the continuous development of ScholarRx by integrating its Virtual Patient Learning (VPL) technology in the Rx Bricks, conducting research, and evaluating the educational impact of ScholarRx.  I am sure our students and faculty will appreciate the value of ScholarRx.” 

GMU uses the innovative Rx Bricks digital learning platform from ScholarRx to better engage and align medical students with the curriculum. This has become especially important as more learning is taking place online. With this new set of resources, faculty teaching GMU students can:

  • Assign specific Rx Bricks through their learning management system
  • Use question banks accompanying the Rx Bricks for both formative and summative assessments, and
  • Provide foundational support to their virtual patient learning sessions.

“Collaboration with ScholarRx has enriched and added value to our existing online learning resources, as the College of Medicine has been able to seamlessly integrate the Rx Bricks in the medical curriculum. Faculty and students alike have embraced it with ease due to the user-friendly nature of the resource,” said Prof. Manda Venkatramana, Vice-Chancellor Academics and Dean, College of Medicine at Gulf Medical University.

“GMU has developed into a leading institution for medical education in the Middle East under the visionary leadership of Chancellor Hamdy and Vice-Chancellor Manda,” said Dr. Tao Le, Founder and CEO of ScholarRx. “We are pleased to support their remarkable work in digital curricular innovation.”

About Gulf Medical University College of Medicine
The vision of the university is to be a leading international academic healthcare institution through the integration of quality health professions education, research, healthcare, and social accountability for sustainable community development. The College of Medicine, in existence since 1998, has managed to not only impart quality medical education, but has also created a network of healthcare services, a conducive research milieu, and developed unique related avenues for professional development, policy, and leadership to meet the healthcare needs of the nation and the region.

About ScholarRx
ScholarRx is a mission-driven education organization currently serving over 150,000 medical students and physician learners annually.  ScholarRx has developed a revolutionary componentized, multi-competency curricular platform that empowers medical schools and their faculty to rapidly develop high-quality education experiences, even in resource-poor environments.

SOURCE ScholarRx

Related Links

http://www.scholarrx.com

Source Article

Read more

University-industry partnership drives UB health care innovation – UB Now: News and views for UB faculty and staff

Research News

Inside the lab at Garwood Medical Devices.

Jackson Hobble, a biomedical engineer at Garwood Medical Devices and a UB biomedical engineering graduate, works in the company’s lab. He is using an in vitro model to test the electrical stimulation technique that BioPrax™ employs to treat infections. Photo: Douglas Levere

By JESSICA SZKLANY

Published December 2, 2020

headshot of Mark Ehrensberger.

Batman and Robin. Peanut butter and jelly. Jobs and Wozniak. Like for these famous duos, when universities and companies join forces, they can achieve far greater impact.

Such is the case for a team of UB researchers and Buffalo-based startup Garwood Medical Devices, who, in partnership, have been awarded $749,000 to evaluate a medical device that utilizes UB-licensed technology and bring it one step closer to clinical use in amputee patients.

The device, called BioPrax™, was created to prevent, control and eliminate bacterial biofilm infections associated with orthopedic implants — a common, costly and potentially devastating problem.

“Metallic implants, such as knee and hip replacements, are prone to getting antibiotic-resistant biofilm infections, which are nearly impossible to cure without removing the implant altogether,” says Wayne Bacon, president and chief executive officer of Garwood Medical Devices. “After removing orthopedic implants, there is a high percentage of failure to ever re-implant another joint replacement, costing patients and the health care system tens of billions of dollars per year and leading to many joint fusions, amputations and deaths.”

The technology behind BioPrax, a cathodic voltage-controlled electrical stimulation (CVCES), is patented by UB and Syracuse University and exclusively licensed by Garwood. When an infection is present, BioPrax delivers the electrical stimulation to a metal implant, such as a prosthetic knee, where it has an antibacterial effect and kills the infecting bacteria.

“We believe this novel infection-control strategy has the potential to introduce a paradigm shift in the treatment of orthopedic implant-associated infections (IAIs), as it would allow for effective treatment without having to remove the implant, thereby maintaining biomechanical stability and mobility of the body segment, and reducing the morbidity and mortality rates associated with recalcitrant IAIs,” says Mark Ehrensberger, co-inventor of the CVCES technology and associate professor in the Department of Biomedical Engineering, a joint program of the School of Engineering and Applied Sciences and the Jacobs School of Medicine and Biomedical Sciences at UB.

Ehrensberger is also director of the Kenneth A Krackow, MD, Orthopaedic Research Laboratory in the Department of Orthopaedics in the Jacobs School.

New grant focuses on helping disabled vets

Previous, nonclinical studies have proven the technology to be effective at disrupting biofilms and killing bacteria, and showed no deleterious impacts to tissue or bone. Last year, Garwood received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) to expedite development and approval of BioPrax.

According to the FDA’s website, the Breakthrough Devices Program targets technologies “that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.” The goal “is to provide patients and health care providers with timely access to these medical devices by speeding up their development, assessment and

Read more

Tri-C, DeVry University Announce Transfer Partnership

SEVEN HILLS, Ohio–(BUSINESS WIRE)–Cuyahoga Community College (Tri-C®) and DeVry University are partnering to provide a seamless pathway that more easily allows Tri-C graduates to pursue a bachelor’s degree.

The partnership creates a next-step option for Tri-C students who earn an associate degree to continue their education and earn a bachelor’s degree in technical management or business at DeVry University, either online or at its Seven Hills location.

“We are pleased to work in collaboration with Tri-C as their commitment to students mirrors ours, and we’re proud to partner with such an outstanding community college to set students up for success,” said Shantanu Bose, Ph.D., provost and chief academic officer at DeVry University. “Together, we are helping to build brighter communities and making the academic transfer process seamless for students to continue their education.”

Tri-C graduates who transfer to DeVry will be assigned a student support advisor, who advises students with course selection, academic planning, financial aid, and graduation requirements.

“Partnerships with four-year colleges such as DeVry are significant in helping our students advance in their career journey,” said Karen Miller, Ph.D., provost and chief academic officer at Tri-C. “We want our graduates to succeed, for their own benefit and for the overall community.”

The agreement with DeVry is one of dozens connecting Tri-C students to opportunities at four-year schools across Ohio and the nation. Visit www.tri-c.edu/transfer to learn more.

Source Article

Read more

Leeds Beckett University extends partnership with UEFA

Leeds Beckett University has extended its partnership with European football governing body UEFA.

(L-R), Frank Ludolph (UEFA), Dr Sergio Lara-Bercial (Leeds Beckett) and Kris Van Der Haegen (UEFA).
(L-R), Frank Ludolph (UEFA), Dr Sergio Lara-Bercial (Leeds Beckett) and Kris Van Der Haegen (UEFA).

The extension will see experts from the university’s Carnegie School of Sport conduct comprehensive evaluations of two of UEFA’s junior football programmes, Football in Schools and PlayMakers.

Football in Schools aims to enhance the quality and quantity of school-based football activities. PlayMakers works to increase the number of girls taking up the game through innovative approaches, including a partnership with Disney.

Sign up to our daily newsletter

The i newsletter cut through the noise

The university will work with UEFA and its 55 member national football associations to co-ordinate and conduct the evaluations.

The initial two-year project will be led by Leeds Beckett’s Dr Sergio Lara-Bercial and a newly-appointed post-doctoral research fellow. The university is currently recruiting for the post and the successful candidate will start in January. The role may be extended for a further two years, depending on the initial outcomes of the two review projects.

Dr Lara-Bercial, a Reader in Sport Coaching at Leeds Beckett, said findings from the two studies would be used to propose modifications and improvements to the delivery of both projects.

He said: “This extension comes after Leeds Beckett completed two literature reviews to inform the development of UEFA’s Football in Schools and PlayMakers Projects in 2019.

“We are proud to be continuing to shape the future of football and wider sport and helping to change lives and communities for the better through improved practice, policy and performance.”

Source Article

Read more

New Wave: Enters into Partnership with the University of West Indies, Mona, Jamaica for Medicinal Drug Discovery

TORONTO, Nov. 26, 2020 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave”) (CSE: SPOR) (FWB: 0XM2) (OTC: TRMND) an investment issuer that provides capital and support services, announced it has entered into a joint venture with The University of West Indies, Mona, Jamaica to conduct drug discovery and highlight knowledge of medicinal plants in Jamaica.

New Wave Holdings Corp. Logo (CNW Group/New Wave Holdings Corp.)

The purpose of this joint venture/partnership is to develop techniques using local microclimate conditions and local research and commercial advantages to explore various natural products and patent opportunities and to conduct drug discovery and highlight knowledge of medicinal plants in Jamaica.

The Parties wish to explore opportunities for:

  • research and development of therapeutic drugs and natural health products that are derived from local plants and fungi;
  • commercial activities that can exploit patents, and other research results, concerning local biodiversity;
  • advancing the knowledge of medicinal plants in Jamaica;
  • increase awareness of medicinal plant health

Under the terms of the strategic partnership, New Wave Holdings will provide capital, resources and further support in drug discovery through the University faculty and facilities.

UWI will undertake research and the objective will be to highlight and further develop various components and/or compounds in early drug discovery stages and explore various plants and fungi that show significant results in the following areas: Cancerous properties, Diabetes, Hypercholesterolemia, and Inflammation. Research at the Facility will be led by various scientific professors that specialize in the key areas listed above.

Daniel Fox, CEO New Wave Holdings comments: “This will be a joint effort between New Wave and UWI brain trust to enhance awareness, innovate new remedies of therapy, and shed light on the medicinal plants and their ultimate consumer health benefits.”

Both New Wave and UWI agree to work together under a model where UWI provides research services (personnel and facilities) that are funded by New Wave. The details of these research projects, the funding needed for each, the ownership of the Intellectual Property that results and the licencing terms if any would be negotiated on a project-by-project basis. 

ABOUT NEW WAVE HOLDINGS CORP.

New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTC: TRMND) is an investment issuer focused on the burgeoning psychedelic sector and support for adaptive and progressive mental health products and therapies. In the psychedelic sector, New Wave will focus on supporting research on active psychedelic compounds, creation of consumer products based on functional mushrooms, and developing an IP portfolio focusing on psilocybin, LSD, MDMA, and ketamine derived treatments for neuropsychiatric diseases. New Wave also contains various health and beauty products within its portfolio of non-psychoactive plants and fungi as it continues to expand its product distribution through vertical integration to provide end to end solutions while capturing a high margin business model.

Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at https://newwavecorp.com

ABOUT THE UNIVERSITY OF WEST INDIES, MONA, JAMAICA 

The University of the West Indies (UWI) Mona campus offers world

Read more

Enters into Partnership with the University of West Indies, Mona, Jamaica for Medicinal Drug Discovery

TORONTO, Nov. 26, 2020 /PRNewswire/ – NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave”) (CSE: SPOR) (FWB: 0XM2) (OTC: TRMND) an investment issuer that provides capital and support services, announced it has entered into a joint venture with The University of West Indies, Mona, Jamaica to conduct drug discovery and highlight knowledge of medicinal plants in Jamaica.

The purpose of this joint venture/partnership is to develop techniques using local microclimate conditions and local research and commercial advantages to explore various natural products and patent opportunities and to conduct drug discovery and highlight knowledge of medicinal plants in Jamaica.

The Parties wish to explore opportunities for:

  • research and development of therapeutic drugs and natural health products that are derived from local plants and fungi;
  • commercial activities that can exploit patents, and other research results, concerning local biodiversity;
  • advancing the knowledge of medicinal plants in Jamaica;
  • increase awareness of medicinal plant health

Under the terms of the strategic partnership, New Wave Holdings will provide capital, resources and further support in drug discovery through the University faculty and facilities.

UWI will undertake research and the objective will be to highlight and further develop various components and/or compounds in early drug discovery stages and explore various plants and fungi that show significant results in the following areas: Cancerous properties, Diabetes, Hypercholesterolemia, and Inflammation. Research at the Facility will be led by various scientific professors that specialize in the key areas listed above.

Daniel Fox, CEO New Wave Holdings comments: “This will be a joint effort between New Wave and UWI brain trust to enhance awareness, innovate new remedies of therapy, and shed light on the medicinal plants and their ultimate consumer health benefits.”

Both New Wave and UWI agree to work together under a model where UWI provides research services (personnel and facilities) that are funded by New Wave. The details of these research projects, the funding needed for each, the ownership of the Intellectual Property that results and the licencing terms if any would be negotiated on a project-by-project basis. 

ABOUT NEW WAVE HOLDINGS CORP.

New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTC: TRMND) is an investment issuer focused on the burgeoning psychedelic sector and support for adaptive and progressive mental health products and therapies. In the psychedelic sector, New Wave will focus on supporting research on active psychedelic compounds, creation of consumer products based on functional mushrooms, and developing an IP portfolio focusing on psilocybin, LSD, MDMA, and ketamine derived treatments for neuropsychiatric diseases. New Wave also contains various health and beauty products within its portfolio of non-psychoactive plants and fungi as it continues to expand its product distribution through vertical integration to provide end to end solutions while capturing a high margin business model.

Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com

ABOUT THE UNIVERSITY OF WEST INDIES, MONA, JAMAICA 

The University of the West Indies (UWI) Mona campus offers world class,

Read more

Purdue University Global, Maricopa Community Colleges form partnership

INDIANAPOLIS — A partnership between Purdue University Global and the Maricopa Community Colleges will facilitate students’ transfer from Maricopa to Purdue Global.

Qualifying students will maximize, as much as possible, the application of their community college coursework and credits to their bachelor’s degree program, with guaranteed admission into Purdue Global and their preferred school of study.

“Purdue Global and the Maricopa Community Colleges are committed to providing greater educational opportunities and services for students transferring between institutions,” Purdue Global Chancellor Frank Dooley said. “This commitment strongly supports the concept of seamless transfer that embraces the principle that transfer students should not be required to repeat courses for learning they have already demonstrated and achieved.”

The maximum number of lower-division credits that can be accepted and applied to a bachelor’s degree at Purdue Global is 86 semester credits. This transfer credit limit will be the difference between total credits required for bachelor’s degree completion and university upper-division requirements. Furthermore, the majority of transfer pathways from Maricopa to Purdue Global will facilitate the application of at least 60 credits when students complete an associate degree and transfer to complete a complementary bachelor’s degree.

“The Maricopa Community Colleges are thrilled to begin this partnership with Purdue Global, which allows our students access to a quality education through an effortless transfer experience,” said Steven R. Gonzales, Maricopa Community Colleges interim chancellor. “Over a third of our students intend to transfer to a university after MCCCD, and through our partnerships with Purdue Global and other four-year universities, we can better serve students with options for continuing their journey in higher education.”

Purdue Global will provide materials, catalogs, and other information to Maricopa Community Colleges advisors to facilitate their understanding of university requirements and academic programs.

“We look forward to welcoming Maricopa students to the Purdue family,” Dooley said.

About Purdue University Global

Purdue University Global delivers personalized online education tailored to the unique needs of adults who have work or life experience beyond the classroom, enabling them to develop essential academic and professional skills with the support and flexibility they need to achieve their career goals. It offers a hyper-tailored path for students to earn an associate, bachelor’s, master’s or doctoral degree, based on their work experience, desired pace, military service, previous college credits and other considerations – no matter where they are in their life journey. Purdue Global serves nearly 35,000 students (as of October 2020), most of whom earn their degree online. It also operates several regional locations nationwide. Purdue Global is a nonprofit, public university accredited by The Higher Learning Commission. It is affiliated with Purdue University’s flagship institution, a highly ranked public research university located in West Lafayette, Indiana. Purdue University also operates two regional campuses in Fort Wayne and Northwest, Indiana, as well as serving close to 6,000 science, engineering and technology students at the Indiana University-Purdue University Indianapolis (IUPUI) campus. For more information, please visit purdueglobal.edu.

About the Maricopa Community Colleges

The Maricopa County Community College District includes 10

Read more

Psychedelic Company MagicMed Forms Strategic Research Partnership With University Of Calgary

This article was originally published on Microdose Psychedelic Insights and appears here with permission.

The innovative team at MagicMed, in pursuit of expanding their novel psychedelic derivative patent library (cleverly dubbed the “Psybrary™”), has formed a strategic partnership with the University of Calgary. The agreement gives the company access to the university’s cutting-edge research facilities and innovation capabilities. 

In a recent article published by the University, MagicMed CEO Dr. Joseph Tucker had this to say about the exciting developments: “There’s millions of dollars worth of equipment, not to mention the world-class intellectual expertise, all of which is accessible because of this ongoing, symbiotic relationship…”

Robust Research Efforts Will Pave the Way Forward for Psychedelics 

The MagicMed team’s dedication to strong research and development efforts has positioned them to be powerful players in the emerging psychedelic medicine space. Indeed, the powerhouse team at Compass Pathways is currently leading the way in psychedelic research and development spending–a promising sign. As psychedelic compounds transition out of the cultural shadows of prohibition and into mainstream medicine, the value of high fidelity clinical trials and robust research efforts cannot be overstated.

magicmed university of calgary research science drug development

Advancing Psychedelic Medicine Through Powerful & Patentable Derivatives

The traditional psychedelic compounds, such as LSD, psilocybin and MDMA, have shown immense therapeutic value in their own right. However, such compounds cannot be patented in their natural state and oftentimes, come with unpleasant side effects. Enter MagicMed, an experienced drug development team customizing psychedelic drugs for maximum efficacy, minimal side effects and patent protection. Through development of their novel Psybrary™, an expansive new inventory of psychedelic derivative drugs will be available to the emerging industry. This new generation of psychedelic derivatives is poised to be more consistent and far superior to their predecessors. While the company is starting their expedition into psychedelic derivatives with psilocybin, they intend to expand their portfolio of compounds to include drugs inspired by other classical psychedelics in the future.

Want to learn more about MagicMed’s exciting Psybrary™? Check out this fascinating episode of the PsyFi podcast where we speak with MagicMed CEO, Dr. Joseph Tucker!

magicmed university of calgary research science drug development

MagicMed’s Symbiotic Partnership With the University of Calgary is Sure to Propel Their R&D Efforts

The process of successfully developing, screening and crafting new psychedelic drugs requires a vast array of resources, technology and clinical expertise. This is exactly why MagicMed’s symbiotic partnership with UCalgary is so powerful and uniquely advantageous to both parties. From the millions of dollars’ worth of cutting-edge technological equipment to the world-class intellectual expertise mentioned by Dr. Tucker, MagicMed the partnership is poised to significantly propel their R&D efforts forward. 

Dr. Tucker goes on to state in the UCalgary article that, ““The university has really become an engine for creating new companies,” he says. “The university has recognized the role they can play to benefit society, more directly than by simply creating smart people, but instead through connecting research and discovery  and transforming it to create solutions for society.”

magicmed university of calgary research science drug development

Powerful Partnerships Between Industry & Academia Promote Psychedelic

Read more

NASA, European Space Agency Formalize Artemis Gateway Partnership

NASA, European Space Agency Formalize Artemis Gateway Partnership

PR Newswire

WASHINGTON, Oct. 27, 2020

WASHINGTON, Oct. 27, 2020 /PRNewswire/ — NASA and ESA (European Space Agency) have finalized an agreement to collaborate on the Artemis Gateway. This agreement is an important element in a broad effort by the United States to engage international partners in sustainable lunar exploration and to demonstrate technologies necessary for a future human mission to Mars. The agreement, signed Tuesday, marks NASA’s first formal commitment to launch international crew members to the lunar vicinity as part of NASA’s Artemis missions.

NASA Logo. (PRNewsFoto/NASA) (PRNewsFoto/) (PRNewsfoto/NASA)
NASA Logo. (PRNewsFoto/NASA) (PRNewsFoto/) (PRNewsfoto/NASA)

The agreement is a critical part of NASA’s efforts to lead an unprecedented global coalition to the Moon. Additional Gateway agreements with other international partners will be executed in the near future, further contributing to the creation of a dynamic and sustainable lunar exploration architecture.

Under this agreement, ESA will contribute habitation and refueling modules, along with enhanced lunar communications, to the Gateway. The refueling module also will include crew observation windows. In addition to providing the hardware, ESA will be responsible for operations of the Gateway elements it provides. ESA also provides two additional European Service Modules (ESMs) for NASA’s Orion spacecraft. These ESMs will propel and power Orion in space on future Artemis missions and provide air and water for its crew.

“This partnership leverages the outstanding cooperation established by the International Space Station as we push forward to the Moon,” said NASA Administrator Jim Bridenstine. “Gateway will continue to expand NASA’s cooperation with international partners like ESA, ensuring the Artemis program results in the safe and sustainable exploration of the Moon after the initial human lunar landing and beyond.”

The International Habitation module (I-Hab) includes components Japan intends to contribute and two docking ports where human landing systems can aggregate. The habitation module also will house the outpost’s Environmental Control and Life Support System (ECLSS), contain accommodations for internal and external science experiments, and provide additional crew work and living space. I-Hab’s ECLSS will augment Gateway’s life support system capabilities provided by the docked Orion, enabling longer durations at the Gateway and support more robust Artemis missions to the lunar surface. 

“The Gateway is designed to be supplemented by additional capabilities provided by our international partners to support sustainable exploration,” said Kathy Lueders, NASA associate administrator for the Human Exploration and Operations Mission Directorate at NASA Headquarters. “Gateway is going to give us access to explore more of the lunar surface than ever before and we’re pleased that partners like ESA will join us on these groundbreaking efforts.”

The Gateway will be assembled in orbit around the Moon as a staging point and enabling platform for missions to the lunar surface, Mars, and other deep space destinations. Approximately one-sixth the size of the International Space Station, the Gateway will function as a way station located tens of thousands of miles from the lunar surface, in a Near Rectilinear Halo Orbit, from which NASA

Read more

GrowerIQ Announces Partnership with High North Labs

Leading Cannabis Testing Lab Partners with Seed-to-Sale Technology Provider to Seamlessly Incorporate Lab Results into Digital Batch Record

  • GrowerIQ & High North Labs announce partnership to build tight integration between seed-to-sale traceability and lab results

  • Partnership includes benefits for GrowerIQ customers, including bulk lab discounts, speedy shipping, better payment terms, etc.

GrowerIQ, a seed-to-sale technology and cannabis cultivation platform provider, is excited to announce a partnership with High North Labs. This partnership will improve the testing process for clients, with seamless, system-to-system integration of lab results transmitted automatically to GrowerIQ’s digital batch record.

The tie-up also includes benefits exclusively for GrowerIQ clients, including discounted testing rates, better payment terms, and more. High North customers that want to simplify their testing process, or upgrade their own traceability systems to GrowerIQ will receive preferential rates.

Andrew Wilson, GrowerIQ’s Chief Operating Officer, commented on the impact that direct system integration will have on GrowerIQ client workflows, “Until now, lab testing across the industry was a very manual process. The lab uploads a PDF of your Certificate of Analysis to their portal, which you must find, download, store, and control somehow. Partnering with a leading lab like High North is a way for us to continue streamlining workflows for our clients – your results are uploaded directly to GrowerIQ, cutting out that manual effort.”

John Slaughter, High North’s Chief Executive Officer, highlighted the impact on data, “Incorporating our detailed lab test results into the broader GrowerIQ traceability chain allows customers to start exploring their data. Licensed producers can analyze how cultivation activities and environmental conditions impact plant characteristics, represented by sample test results. GrowerIQ’s data insights team can analyze which activities correlate to which terpene expression or THC/CBD profile. This type of analysis is how we push the industry forward.”

ABOUT GROWERIQ

GrowerIQ is a compliant cannabis seed-to-sale and cultivation management platform, designed in partnership with a Master Grower. It was the first platform to integrate all facility systems, including sensors, controls, QMS, and ERP, into a single interface. GrowerIQ leverages proprietary machine learning technology to automate your facility and provide quality-boosting cultivation insights. GrowerIQ changes the way cultivators use software – transforming a regulatory requirement into a platform to learn, analyze, and improve performance.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201022006241/en/

Contacts

Andrew Wilson, COO
+1 (855) 892-7500
[email protected]

Media Room

Source Article

Read more